Optimapharmsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-08-26
Share capital
5,000.00 PLN
Registered address
ul. Na Zjeździe 11, 30-527 Kraków, Poland

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$4,613

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 301 days for 2023).

  • 202526/06/2026
  • 202404/07/2025
  • 202312/05/2025
  • 202202/11/2023
  • 202128/10/2022
  • 202012/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 15%
City · Kraków4,202 / 16,209
Top 26%
Voivodeship · Małopolskie8,320 / 27,820
Top 30%
Country · Poland91,727 / 297,873
Top 31%

Results vs industry

Revenue
This companyUSD 974.75kMedianUSD 55.24kAverageUSD 2.70m
Net profit
This companyUSD 78.92kMedianUSD -1.27kAverageUSD -92.18k
Operating costs
This companyUSD 845.15kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 414.53kMedianUSD 133.19kAverageUSD 3.03m

Authorized Representatives

Ivana Waller – Dyrektor Zarządu
Mirna Šenjug Novak – Dyrektor Zarządu

Manner of representation

Each member of the management board represents the company independently.

Ownership

OwnerSharesShare valueStake
Optimapharm Društvo S Ograničenom Odgovornošču za Zastupanje i Usluge
100$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2019-09-28.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
MedappS.A.
SkinlabP.S.A.
EIT Rawmaterials Clc Eastsp. z o.o.
COS LabP.S.A.
IntelliseqS.A.
Przedsiębiorstwo Wielobranżowe Genezasp. z o.o.
Medtransfersp. z o.o.
Oncotherics PolandS.A.
Fusiomicasp. z o.o.
Ncage TherapeuticsS.A.

FAQ

Last updated: 2026-10-07